Press releases
- Immunovia's new lab staffed and operational after rapid implementation
- BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)
- NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)
- Immunovia carries out a rights issue of units of approximately SEK 70 million and raises bridge loans
- Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina
- Immunovia publishes the annual report for 2023
- Immunovia Publishes Interim Report for January-March 2024
- Invitation to Immunovia's Q1 presentation
- Immunovia announces updated financial calendar
- Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
More ▼
Key statistics
As of last trade, Immunovia AB (publ) (1YR:BER) traded at 0.1644, 3,909.76% above the 52 week low of 0.0041 set on Oct 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1644 |
---|---|
High | 0.1644 |
Low | 0.1644 |
Bid | 0.123 |
Offer | 0.206 |
Previous close | 0.1644 |
Average volume | 0.00 |
---|---|
Shares outstanding | 45.29m |
Free float | 34.29m |
P/E (TTM) | -- |
Market cap | 78.89m SEK |
EPS (TTM) | -6.06 SEK |
Data delayed at least 15 minutes, as of Jul 05 2024 07:06 BST.
More ▼